Calidi Biotherapeutics Inc. (CLDI AMEX) stock market data APIs
$1.0338
0.01(1%)
as of October 9, 2026
Try our APIs with
free plan!
Calidi Biotherapeutics Inc. Financial Data Overview
Price chart is built with
Anychart
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Prev. Close
1.0338
Open
1.0455
High
1.0499
Low
1.0253
52 wk Range
0.986-27.84
Market Cap
3 787 K
Shares Outstanding
3 676 K
EPS
-2.94
Beta
1.329
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Calidi Biotherapeutics Inc. data using free add-ons & libraries
Get Calidi Biotherapeutics Inc. Fundamental Data
Calidi Biotherapeutics Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -16 137 000
- Earnings Per Share: -36
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Calidi Biotherapeutics Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Calidi Biotherapeutics Inc. News
New
Calidi Biotherapeutics gets NYSE compliance warning but stock surprises
* Calidi Biotherapeutics (CLDI [https://seekingalpha.com/symbol/CLDI]) announced on Friday that it received a NYSE American compliance notice for failing to meet the exchange’s $4M minimum stockho...
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Calidi Biotherapeutics, Inc SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the develo...
Calidi Announces Reverse Stock Split; Shares Tumble 15% In Premarket Trading
(RTTNews) - Calidi Biotherapeutics, Inc. (CLDI), a biotechnology company, announced a proposed 1-for-16 reverse stock split of its outstanding common stock, effective July 31, 2026. The company's com...
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
SAN DIEGO, July 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a biotechnology company pioneering the development of targeted ge...
Get Calidi Biotherapeutics Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.